Jordan Altman is a partner in the Intellectual Property Transactions Group.

He practices corporate law with an emphasis on structuring, drafting and negotiating agreements that focus on the development, transfer, procurement, commercialization and maintenance of intellectual property and technology. He also counsels clients, including public companies, growing technology-driven businesses and start-ups on intellectual property portfolio development. He has extensive experience working with clients in the pharmaceutical, medical device, chemical, entertainment, sports, automotive, software and financial services industries.

Prior to joining Shearman & Sterling, Jordan practiced patent and trademark prosecution for pharmaceutical and medical device companies and participated in patent and trade secret litigation. He also examined patent applications for inventions relating to immunological functions at the U.S. Patent and Trademark Office before obtaining his law degree.

• General Electric Company on the combination of GE Oil & Gas with Baker Hughes, Inc. to create a $32 billion oilfield technology provider.
• American Axle & Manufacturing Holdings, Inc. in connection with its $1.6 billion cash and stock acquisition of Metaldyne Performance Group Inc.
• Taikang Insurance Group on the establishment of a joint venture with New York-based NorthStar Realty Finance Corp.
• The Dow Chemical Company in connection with the carve-out sale of its Chlor-Alkali businesses to Olin Corporation; and the disposition of its Calcium Chloride business and its Morton Salt business; and in connection with various divestitures and joint ventures.
• Boston Scientific Corporation in its acquisition of the urology portfolio of American Medical Systems, Inc. from Endo International plc and in connection with multiple divestitures.
• Venner Medical in connection with agreements for the development and testing of medical devices.
• Citigroup Inc. in the acquisition and disposition of various domestic and international credit card receivables portfolios, including the pending acquisition of the Costco co-branded credit card portfolio from American Express Company; and with the acquisition from Capital One Financial Corporation of credit card receivables and accounts related to Best Buy Co. Inc.’s existing credit card program and in the negotiation of program agreements with retailers for the creation of credit card programs.
• Citibank N.A. in its sale of Citi’s Alternative Investor Services business, comprised of Hedge Fund Services and Private Equity Fund Services, to SS&C Technologies.
• Altice N.V. in its acquisition of Cablevision Systems Corporation.
• Liberty Global plc in its pending acquisition of Cable & Wireless Communications plc.
• Legg Mason in its acquisition of a majority stake in Clarion Partners Holdings LLC.
• Intercontinental Exchange, Inc. in its acquisition of Trayport Limited from BGC Partners.
• Sumitomo Rubber Industries, Ltd. in the dissolution of its global alliance with The Goodyear Tire & Rubber Company.
• SunGard Data Systems Inc. in its acquisition by Fidelity National Information Services Inc.
• J.D. Power & Associates in its acquisition of the Used Car Guide Business of the National Automobile Dealers Association.
• Lafarge SA in the sale of its North American Gypsum business to an affiliate of Lone Star Funds.
• Stone Point Capital in connection with the merger of Pierpont Securities LLC with Amherst Securities Group LP.
• WebMD Health Corp. in various corporate and transactional matters, including its sale of Porex Corporation.
• Corning Incorporated in its acquisition of Axygen BioScience, Inc. from American Capital, Ltd.
• Itaú Unibanco in connection with multiple software license agreements.
• Daimler AG in its sale of the automotive and financial services business of the Chrysler Group to Cerberus Capital Management.
• New England Sports Ventures (the parent company of the Boston Red Sox) in its acquisition of the Liverpool Football Club of the English Premier League.
• LMA North America, Inc. in connection with a global supply and distribution agreement relating to medical devices.
• Novartis AG in connection with its acquisition of the over-the-counter consumer medicines business of Bristol Myers Squibb Company.
• Sun Pharmaceutical Industries in connection with its purchase of Taro Pharmaceutical Industries.
• Torchlight Investors LLC in connection with a multi-platform outsourcing agreement.
• Tata Tea Ltd. in its acquisition of an equity interest in Glacéau, the maker of Vitaminwater.
• Quest Diagnostics Incorporated in connection with multiple acquisitions.
• Genmab A/S in connection with various technology license and commercialization agreements for a pharmaceutical compound.
• Aabar Investments PJSC in its acquisition of an equity interest in Virgin Galactic.
• Various agreements for funding the clinical development of therapeutic compounds belonging to Dynavax Technologies Corp. and Ionis Pharmaceuticals.
• China Mobile Ltd. in connection with a joint venture with Vodafone and Verizon Wireless for the development of mobile phone technologies.
• International Chemical Investors Group in connection with multiple acquisitions of pharmaceutical manufacturing and formulation businesses.
• American Axle & Manufacturing, Inc. in connection with establishing a joint venture in China for the development of automotive technologies.
• Caris Life Sciences, Inc. in connection with the sale of its anatomic pathology business to Miraca Holdings.
• The Laryngeal Mask Company in connection with technology and patent license agreements for medical devices.
• Dover Corporation in its acquisition of JK Group S.p.A. from Wise SGR S.p.A. and Alcedo SGR S.p.A.
• Wausau Paper Corp. in its acquisition by Svenska Cellulosa Aktiebolaget.
• HeidelbergCement AG in the sale of Hanson Building Products to Lone Star Funds.
• Helm Corporation in connection with the sale of Helm Bank SA to CorpBanca Colombia, a subsidiary of CorpBanca SA.
• Amundi Group in its acquisition, through subsidiary Amundi USA, Inc., of all of the outstanding shares of Smith Breeden Associates, Inc.
• Paharpur Cooling Towers Ltd. in its acquisition of SPX Corporation’s dry cooling business.
• PointState Argentum LLC in its acquisition of 50% stake, along with LAIG, in Genneia S.A.
• LMA International N.V. in its acquisition of Wolfe Tory Medical, Inc. and its sale to Teleflex, Inc.

Awards & Accolades

• Recognized for Technology: Transactions by Legal 500 US 2016
• Shearman & Sterling ranked in Top 10 for Advising on Private Technology Transactions in PrivCo’s list of Top Legal Advisors in Tech (2015)

Publications

• Co-Author, “INSIGHT: Registering Immoral, Scandalous Trademarks Following Brunetti,” Bloomberg Law, Sept. 2019
• Co-Author, “Safe Secrets: Dealing with Data Privacy Issues in M&A,” Mergermarket, Mar. 2017
• Co-Author, “License to Leak: The DTSA and the Risks of Immunity,” Intellectual Property & Technology Law Journal, Oct. 2016
• Co-Author, “The Mega Scale of Meso Scale,” Intellectual Property Magazine, Sept. 2015
• Co-Author, “Prioritizing Patents for Stem Cell Inventions,” LAW360, Feb. 11, 2009
• Co-Author, “On Shaky Ground (an analysis of Propat v. Rpost),” Patent World, May 2007